E060 Testing a new prototype osteoporosis shared decision-making intervention in UK Fracture Liaison Services: patient and clinician perspectives of ‘iFraP’

Bullock, Laurna; Tyler, Natasha; Thompson, Maddy; Ryan, Sarah; Lefroy, Janet; Leyland, Sarah; Fleming, Jane; Clark, Emma M; Thomas, Simon; Gidlow, Christopher; Iglesias-Urrutia, Cynthia P; O'Neill, Terence W; Mallen, Christian D; Jinks, Clare; Paskins, Zoe

Abstract

Shared decision-making (SDM) is a joint process in which a person and healthcare professional work together to reach decisions about care. The Improving uptake of Fracture Prevention drug treatments (iFraP) study developed a prototype theoretically-informed intervention consisting of a computerised decision aid (DA) and Fracture Liaison Service (FLS) clinician training package to improve SDM about osteoporosis medicines. This abstract focuses on the early prototype iFraP in-practice testing phase that explored perceived acceptability of iFraP by those using it, barriers to, and facilitators of, implementation of the prototype iFraP in practice, and necessary changes required ahead of a full-scale randomised controlled trial (RCT).

Citation

Bullock, L., Tyler, N., Thompson, M., Ryan, S., Lefroy, J., Leyland, S., …Paskins, Z. (2023, April). E060 Testing a new prototype osteoporosis shared decision-making intervention in UK Fracture Liaison Services: patient and clinician perspectives of ‘iFraP’. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK

• Presentation Conference Type: Poster
• Conference Name: British Society for Rheumatology Annual Conference 2023
• Conference Location: Manchester Central Convention Complex, Manchester, UK
• Start Date: Apr 24, 2023
• End Date: Apr 26, 2023
• Deposit Date: May 26, 2023
• Series ISSN: 1462-0324: 1462-0332
• DOI: https://doi.org/10.1093/rheumatology/kead104.309
• Keywords: Pharmacology (medical); Rheumatology
• Publisher URL: https://academic.oup.com/rheumatology/article/62/Supplement_2/kead104.309/7136529